Digoxin for Recurrent Prostate Cancer

NCT01162135 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Digoxin

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University